retatrutide benefits clinical trials ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Retatrutide (“reta”) is an experimental

Finally, there is some conflicting evidence about the effect of GLP-1RA therapy and muscle loss

It works by boosting cellular immunity, especially in patients with suppressed T-cell function, enabling the body to better fight infection (8)

And the Aon multi-year study found something even more striking: among patients who maintained consistent use, the rate of medical cost growth was cut roughly in half within two years

Although they adjusted the data for other influential factors like age, sex, ethnicity, other health conditions, and medication use, they cannot exclude other elements that may have impacted the results

Obesity is multi-factorial